OBJECTIVE: Alcohol use is prevalent among HIV-infected people and is associated with lower antiretroviral adherence and high-risk sexual and injection behaviors. We sought to determine factors associated with alcohol use among HIV-infected women engaged in clinical care and if baseline alcohol use was associated with time to combination antiretroviral therapy (cART) and death in this population. METHODS: In an observational clinical cohort, alcohol consumption at the initial medical visit was examined and categorized as heavy, occasional, past, or no use. We used multinomial logistic regression to test preselected covariates and their association with baseline alcohol consumption. We then examined the association between alcohol use and time to cART and time to death using Kaplan-Meier statistics and Cox proportional hazards regression. RESULTS: Between 1997 and 2006, 1030 HIV-infected women enrolled in the cohort. Assessment of alcohol use revealed occasional and hazardous consumption in 29% and 17% of the cohort, respectively; 13% were past drinkers. In multivariate regression, heavy drinkers were more likely to be infected with hepatitis C than nondrinkers (relative risk ratios [RRR] 2.06, 95% confidence interval [CI] 1.29-3.44) and endorse current drug (RRR 3.51, 95% CI 2.09-5.91) and tobacco use (RRR 3.85 95% CI 1.81-8.19). Multivariable Cox regression adjusting for all clinical covariates demonstrated an increased mortality risk (hazard ratio [HR] 1.40, 95% CI 1.00-1.97, p < 0.05) among heavy drinkers compared to nondrinkers but no delays in cART initiation (1.04 95% CI 0.81-1.34) CONCLUSIONS: Among this cohort of HIV-infected women, heavy alcohol consumption was independently associated with earlier death. Baseline factors associated with heavy alcohol use included tobacco use, hepatitis C, and illicit drug use. Alcohol is a modifiable risk factor for adverse HIV-related outcomes. Providers should consistently screen for alcohol consumption and refer HIV-infected women with heavy alcohol use for treatment.
OBJECTIVE:Alcohol use is prevalent among HIV-infected people and is associated with lower antiretroviral adherence and high-risk sexual and injection behaviors. We sought to determine factors associated with alcohol use among HIV-infectedwomen engaged in clinical care and if baseline alcohol use was associated with time to combination antiretroviral therapy (cART) and death in this population. METHODS: In an observational clinical cohort, alcohol consumption at the initial medical visit was examined and categorized as heavy, occasional, past, or no use. We used multinomial logistic regression to test preselected covariates and their association with baseline alcohol consumption. We then examined the association between alcohol use and time to cART and time to death using Kaplan-Meier statistics and Cox proportional hazards regression. RESULTS: Between 1997 and 2006, 1030 HIV-infectedwomen enrolled in the cohort. Assessment of alcohol use revealed occasional and hazardous consumption in 29% and 17% of the cohort, respectively; 13% were past drinkers. In multivariate regression, heavy drinkers were more likely to be infected with hepatitis C than nondrinkers (relative risk ratios [RRR] 2.06, 95% confidence interval [CI] 1.29-3.44) and endorse current drug (RRR 3.51, 95% CI 2.09-5.91) and tobacco use (RRR 3.85 95% CI 1.81-8.19). Multivariable Cox regression adjusting for all clinical covariates demonstrated an increased mortality risk (hazard ratio [HR] 1.40, 95% CI 1.00-1.97, p < 0.05) among heavy drinkers compared to nondrinkers but no delays in cART initiation (1.04 95% CI 0.81-1.34) CONCLUSIONS: Among this cohort of HIV-infectedwomen, heavy alcohol consumption was independently associated with earlier death. Baseline factors associated with heavy alcohol use included tobacco use, hepatitis C, and illicit drug use. Alcohol is a modifiable risk factor for adverse HIV-related outcomes. Providers should consistently screen for alcohol consumption and refer HIV-infectedwomen with heavy alcohol use for treatment.
Authors: Xiuhong Li; Joseph B Margolick; Craig S Conover; Sheila Badri; Sharon A Riddler; Mallory D Witt; Lisa P Jacobson Journal: J Acquir Immune Defic Syndr Date: 2005-03-01 Impact factor: 3.731
Authors: Jennifer V Campbell; Holly Hagan; Mary H Latka; Richard S Garfein; Elizabeth T Golub; Micaela H Coady; David L Thomas; Steffanie A Strathdee Journal: Drug Alcohol Depend Date: 2005-08-29 Impact factor: 4.492
Authors: Amy C Justice; Elaine Lasky; Kathleen A McGinnis; Melissa Skanderson; Joseph Conigliaro; Shawn L Fultz; Kristina Crothers; Linda Rabeneck; Maria Rodriguez-Barradas; Sharon B Weissman; Kendall Bryant Journal: Med Care Date: 2006-08 Impact factor: 2.983
Authors: R S Braithwaite; J Conigliaro; M S Roberts; S Shechter; A Schaefer; K McGinnis; M C Rodriguez; L Rabeneck; K Bryant; A C Justice Journal: AIDS Care Date: 2007-04
Authors: Jeffrey H Samet; Debbie M Cheng; Howard Libman; David P Nunes; Julie K Alperen; Richard Saitz Journal: J Acquir Immune Defic Syndr Date: 2007-10-01 Impact factor: 3.731
Authors: Kathleen M Malee; Claude A Mellins; Yanling Huo; Katherine Tassiopoulos; Renee Smith; Patricia A Sirois; Susannah M Allison; Deborah Kacanek; Suad Kapetanovic; Paige L Williams; Mitzie L Grant; Daniel Marullo; Angela A Aidala Journal: J Acquir Immune Defic Syndr Date: 2014-04-15 Impact factor: 3.731
Authors: Anne K Monroe; Bryan Lau; Michael J Mugavero; William C Mathews; Kenneth H Mayer; Sonia Napravnik; Heidi E Hutton; Hongseok S Kim; Sarah Jabour; Richard D Moore; Mary E McCaul; Katerina A Christopoulos; Heidi C Crane; Geetanjali Chander Journal: J Acquir Immune Defic Syndr Date: 2016-12-01 Impact factor: 3.731
Authors: J Danielle Sharpe; Zhi Zhou; César G Escobar-Viera; Jamie P Morano; Robert J Lucero; Gladys E Ibañez; Mark Hart; Christa L Cook; Robert L Cook Journal: Subst Abus Date: 2017-09-01 Impact factor: 3.716
Authors: Keri L Calkins; Catherine R Lesko; Geetanjali Chander; Richard D Moore; Bryan Lau Journal: J Acquir Immune Defic Syndr Date: 2018-03-01 Impact factor: 3.731
Authors: Nikita Barai; Anne Monroe; Catherine Lesko; Bryan Lau; Heidi Hutton; Cui Yang; Anika Alvanzo; Mary Elizabeth McCaul; Geetanjali Chander Journal: AIDS Behav Date: 2017-07
Authors: Emily C Williams; Judith A Hahn; Richard Saitz; Kendall Bryant; Marlene C Lira; Jeffrey H Samet Journal: Alcohol Clin Exp Res Date: 2016-09-22 Impact factor: 3.455
Authors: Jennifer L Glick; Aimee Huang; Rienna Russo; Belinda Jivapong; Vijayasundaram Ramasamy; Lori Rosman; Danielle Pelaez; Katherine H A Footer; Susan G Sherman Journal: Drug Alcohol Depend Date: 2020-08-02 Impact factor: 4.492